Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
更正：帕博利珠单抗、放射疗法和免疫调节五药鸡尾酒疗法治疗既往接受过治疗的持续性、复发性或转移性宫颈癌或子宫内膜癌患者：II期PRIMMO研究结果
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03873-5
De Jaeghere, Emiel A; Tuyaerts, Sandra; Van Nufel, An M T; Belmans, Ann; Bogaerts, Kris; Baiden-Amissah, Regina; Lippens, Lien; Vuylsteke, Peter; Henry, Stéphanie; Trinh, Xuan Bich; van Dam, Peter A; Aspeslagh, Sandrine; De Caluwé, Alex; Naert, Eline; Lambrechts, Diether; Hendrix, An; De Wever, Olivier; Van de Vijver, Koen K; Amant, Frédéric; Vandecasteele, Katrien; Denys, Hannelore G
肿瘤
子宫内膜癌
肿瘤免疫
多发性骨髓瘤
宫颈癌
免疫/内分泌
